NCT03039712

Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 37,000 (estimated)
• Sponsor: Medtronic · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The primary purpose of the study is to meet the CMS mandated Coverage with Evidence Development requirement in the National Coverage Determination for Leadless Pacemakers as they apply to Medtronic Micra devices. The study uses administrative claims data of the Medicare population implanted with single-chamber ventricular pacemakers. Patients are enrolled through submission of claims or encounter data to CMS.

Detailed description

Micra CED study is a study of the Medicare beneficiary population implanted with single-chamber ventricular pacemakers, and will be executed by analyzing administrative claims data. The study consists of two primary objectives: estimate the: (1) acute overall complication rate and (2) the 2-year survival rate of patients implanted with a Micra leadless pacemaker. As part of the secondary objectives of the study, a comparative analysis of Micra leadless pacemakers to single-chamber ventricular transvenous pacemakers will be conducted. The analysis will be in CMS claims data and is subject to a central IRB. However, individual hospitals are not engaged in research and local IRB oversight is not necessary.

Conditions

• Bradycardia

Timeline

• Start date: 2017-03-10
• Primary completion: 2029-06-01
• Completion: 2029-06-01
• First posted: 2017-02-01
• Last updated: 2025-09-29

Locations

1 site across 1 country: United States